DCM
EW icon

Dorato Capital Management’s Edwards Lifesciences EW Stock Holding History

Dorato Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.8K Hold
345
– – 0.02% 200
2026
Q1 		$28.2K Hold
345
– – 0.02% 199
2025
Q4 		$28.7K Buy
+345
New +$28.3K 0.02% 196

Other funds holding EW

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Dorato Capital Management's EW Position: Q2 2026 in Review

Dorato Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 345 shares worth $31.8K. The position accounts for 0.02% of the portfolio, ranked #200.

Dorato Capital Management first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 727 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Dorato Capital Management held 345 shares of Edwards Lifesciences worth $31.8K as of Q2 2026.
  • Dorato Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.02% of Dorato Capital Management's portfolio in Q2 2026, its #200 holding.
  • Dorato Capital Management first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 727 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Dorato Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.